Click for best price
Antiallergic Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 11300 million
|
Forecast Market size by 2029 |
US$ 14040 million
|
| Growth Rate |
CAGR of 3.2% |
Number of Pages |
66 Pages |
The global Anti-allergic Drugs market was valued at US$ 11300 million in 2022 and is projected to reach US$ 14040 million by 2029, at a CAGR of 3.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Anti-allergic Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Anti-allergic Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Anti-allergic Drugs market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Allergic reaction, or allergy, refers to tissue damage or physiological dysfunction caused by the stimulation of antigenic substances. It is a process of immune pathological damage. The drugs used to prevent and treat allergic diseases caused by various antigenic substances such as bacteria, viruses, parasites, pollen, etc. are anti-allergic drugs, also known as anti-allergic drugs.
This report aims to provide a comprehensive presentation of the global market for Anti-allergic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-allergic Drugs. This report contains market size and forecasts of Anti-allergic Drugs in global, including the following market information:
- Global Anti-allergic Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global top two companies hold a share over 10%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30 and 20.
We surveyed the Anti-allergic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-allergic Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Anti-allergic Drugs Market Segment Percentages, by Type, 2022 (%)
Global Anti-allergic Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Anti-allergic Drugs Market Segment Percentages, by Application, 2022 (%)
Global Anti-allergic Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Anti-allergic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Anti-allergic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Anti-allergic Drugs revenues share in global market, 2022 (%)
key players include:
- Pfizer
- Bayer
- Merck
- GlaxoSmithKline
- Sanofi
- Mitsubishi Tanabe Pharma
- UCB Pharma
- Hainan Poly Pharm
- Yangzijiang Pharmaceutical
- Shionogi
- Dawnrays Pharma
- Zhejiang Wolwo Bio-Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-allergic Drugs, market overview.
Chapter 2: Global Anti-allergic Drugs market size in revenue.
Chapter 3: Detailed analysis of Anti-allergic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-allergic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-allergic Drugs Market, Global Outlook and Forecast 2023-2032 |
| Market size in 2022 |
US$ 11300 million
|
| Forecast Market size by 2029 |
US$ 14040 million
|
| Growth Rate |
CAGR of 3.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-allergic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-allergic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-allergic Drugs Overall Market Size
2.1 Global Anti-allergic Drugs Market Size: 2022 VS 2032
2.2 Global Anti-allergic Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-allergic Drugs Players in Global Market
3.2 Top Global Anti-allergic Drugs Companies Ranked by Revenue
3.3 Global Anti-allergic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-allergic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-allergic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-allergic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-allergic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-allergic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-allergic Drugs Market Size Markets, 2022 & 2032
4.1.2 Oral
4.1.3 External Use
4.2 By Type - Global Anti-allergic Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-allergic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-allergic Drugs Revenue, 2024-2032
4.2.3 By Type - Global Anti-allergic Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-allergic Drugs Market Size, 2022 & 2032
5.1.2 Online
5.1.3 Offline
5.2 By Application - Global Anti-allergic Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-allergic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-allergic Drugs Revenue, 2024-2032
5.2.3 By Application - Global Anti-allergic Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Anti-allergic Drugs Market Size, 2022 & 2032
6.2 By Region - Global Anti-allergic Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-allergic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-allergic Drugs Revenue, 2024-2032
6.2.3 By Region - Global Anti-allergic Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Anti-allergic Drugs Revenue, 2018-2032
6.3.2 US Anti-allergic Drugs Market Size, 2018-2032
6.3.3 Canada Anti-allergic Drugs Market Size, 2018-2032
6.3.4 Mexico Anti-allergic Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Anti-allergic Drugs Revenue, 2018-2032
6.4.2 Germany Anti-allergic Drugs Market Size, 2018-2032
6.4.3 France Anti-allergic Drugs Market Size, 2018-2032
6.4.4 U.K. Anti-allergic Drugs Market Size, 2018-2032
6.4.5 Italy Anti-allergic Drugs Market Size, 2018-2032
6.4.6 Russia Anti-allergic Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Anti-allergic Drugs Market Size, 2018-2032
6.4.8 Benelux Anti-allergic Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Anti-allergic Drugs Revenue, 2018-2032
6.5.2 China Anti-allergic Drugs Market Size, 2018-2032
6.5.3 Japan Anti-allergic Drugs Market Size, 2018-2032
6.5.4 South Korea Anti-allergic Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Anti-allergic Drugs Market Size, 2018-2032
6.5.6 India Anti-allergic Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Anti-allergic Drugs Revenue, 2018-2032
6.6.2 Brazil Anti-allergic Drugs Market Size, 2018-2032
6.6.3 Argentina Anti-allergic Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-allergic Drugs Revenue, 2018-2032
6.7.2 Turkey Anti-allergic Drugs Market Size, 2018-2032
6.7.3 Israel Anti-allergic Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Anti-allergic Drugs Market Size, 2018-2032
6.7.5 UAE Anti-allergic Drugs Market Size, 2018-2032
7 Anti-allergic Drugs Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Anti-allergic Drugs Major Product Offerings
7.1.4 Pfizer Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Bayer
7.2.1 Bayer Company Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Anti-allergic Drugs Major Product Offerings
7.2.4 Bayer Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.2.5 Bayer Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Anti-allergic Drugs Major Product Offerings
7.3.4 Merck Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Anti-allergic Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Anti-allergic Drugs Major Product Offerings
7.5.4 Sanofi Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Mitsubishi Tanabe Pharma
7.6.1 Mitsubishi Tanabe Pharma Company Summary
7.6.2 Mitsubishi Tanabe Pharma Business Overview
7.6.3 Mitsubishi Tanabe Pharma Anti-allergic Drugs Major Product Offerings
7.6.4 Mitsubishi Tanabe Pharma Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.6.5 Mitsubishi Tanabe Pharma Key News & Latest Developments
7.7 UCB Pharma
7.7.1 UCB Pharma Company Summary
7.7.2 UCB Pharma Business Overview
7.7.3 UCB Pharma Anti-allergic Drugs Major Product Offerings
7.7.4 UCB Pharma Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.7.5 UCB Pharma Key News & Latest Developments
7.8 Hainan Poly Pharm
7.8.1 Hainan Poly Pharm Company Summary
7.8.2 Hainan Poly Pharm Business Overview
7.8.3 Hainan Poly Pharm Anti-allergic Drugs Major Product Offerings
7.8.4 Hainan Poly Pharm Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.8.5 Hainan Poly Pharm Key News & Latest Developments
7.9 Yangzijiang Pharmaceutical
7.9.1 Yangzijiang Pharmaceutical Company Summary
7.9.2 Yangzijiang Pharmaceutical Business Overview
7.9.3 Yangzijiang Pharmaceutical Anti-allergic Drugs Major Product Offerings
7.9.4 Yangzijiang Pharmaceutical Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.9.5 Yangzijiang Pharmaceutical Key News & Latest Developments
7.10 Shionogi
7.10.1 Shionogi Company Summary
7.10.2 Shionogi Business Overview
7.10.3 Shionogi Anti-allergic Drugs Major Product Offerings
7.10.4 Shionogi Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.10.5 Shionogi Key News & Latest Developments
7.11 Dawnrays Pharma
7.11.1 Dawnrays Pharma Company Summary
7.11.2 Dawnrays Pharma Business Overview
7.11.3 Dawnrays Pharma Anti-allergic Drugs Major Product Offerings
7.11.4 Dawnrays Pharma Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.11.5 Dawnrays Pharma Key News & Latest Developments
7.12 Zhejiang Wolwo Bio-Pharma
7.12.1 Zhejiang Wolwo Bio-Pharma Company Summary
7.12.2 Zhejiang Wolwo Bio-Pharma Business Overview
7.12.3 Zhejiang Wolwo Bio-Pharma Anti-allergic Drugs Major Product Offerings
7.12.4 Zhejiang Wolwo Bio-Pharma Anti-allergic Drugs Revenue in Global Market (2018-2023)
7.12.5 Zhejiang Wolwo Bio-Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-allergic Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-allergic Drugs Market Drivers in Global Market
Table 3. Anti-allergic Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-allergic Drugs in Global Market
Table 5. Top Anti-allergic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-allergic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-allergic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-allergic Drugs Product Type
Table 9. List of Global Tier 1 Anti-allergic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-allergic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-allergic Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Anti-allergic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-allergic Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Anti-allergic Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Anti-allergic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-allergic Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Anti-allergic Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Anti-allergic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-allergic Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Anti-allergic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-allergic Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Anti-allergic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-allergic Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Anti-allergic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-allergic Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Anti-allergic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-allergic Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Anti-allergic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-allergic Drugs Revenue, (US$, Mn), 2024-2032
Table 30. Pfizer Company Summary
Table 31. Pfizer Anti-allergic Drugs Product Offerings
Table 32. Pfizer Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Bayer Company Summary
Table 35. Bayer Anti-allergic Drugs Product Offerings
Table 36. Bayer Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Bayer Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Anti-allergic Drugs Product Offerings
Table 40. Merck Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Anti-allergic Drugs Product Offerings
Table 44. GlaxoSmithKline Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Anti-allergic Drugs Product Offerings
Table 48. Sanofi Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. Mitsubishi Tanabe Pharma Company Summary
Table 51. Mitsubishi Tanabe Pharma Anti-allergic Drugs Product Offerings
Table 52. Mitsubishi Tanabe Pharma Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Mitsubishi Tanabe Pharma Key News & Latest Developments
Table 54. UCB Pharma Company Summary
Table 55. UCB Pharma Anti-allergic Drugs Product Offerings
Table 56. UCB Pharma Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. UCB Pharma Key News & Latest Developments
Table 58. Hainan Poly Pharm Company Summary
Table 59. Hainan Poly Pharm Anti-allergic Drugs Product Offerings
Table 60. Hainan Poly Pharm Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Hainan Poly Pharm Key News & Latest Developments
Table 62. Yangzijiang Pharmaceutical Company Summary
Table 63. Yangzijiang Pharmaceutical Anti-allergic Drugs Product Offerings
Table 64. Yangzijiang Pharmaceutical Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Yangzijiang Pharmaceutical Key News & Latest Developments
Table 66. Shionogi Company Summary
Table 67. Shionogi Anti-allergic Drugs Product Offerings
Table 68. Shionogi Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Shionogi Key News & Latest Developments
Table 70. Dawnrays Pharma Company Summary
Table 71. Dawnrays Pharma Anti-allergic Drugs Product Offerings
Table 72. Dawnrays Pharma Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Dawnrays Pharma Key News & Latest Developments
Table 74. Zhejiang Wolwo Bio-Pharma Company Summary
Table 75. Zhejiang Wolwo Bio-Pharma Anti-allergic Drugs Product Offerings
Table 76. Zhejiang Wolwo Bio-Pharma Anti-allergic Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Zhejiang Wolwo Bio-Pharma Key News & Latest Developments
List of Figures
Figure 1. Anti-allergic Drugs Segment by Type in 2022
Figure 2. Anti-allergic Drugs Segment by Application in 2022
Figure 3. Global Anti-allergic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-allergic Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Anti-allergic Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-allergic Drugs Revenue in 2022
Figure 8. By Type - Global Anti-allergic Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Anti-allergic Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Anti-allergic Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Anti-allergic Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Anti-allergic Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Anti-allergic Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Anti-allergic Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Anti-allergic Drugs Revenue Market Share, 2018-2032
Figure 16. US Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Anti-allergic Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Anti-allergic Drugs Revenue Market Share, 2018-2032
Figure 28. China Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Anti-allergic Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Anti-allergic Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Anti-allergic Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Pfizer Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bayer Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Mitsubishi Tanabe Pharma Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. UCB Pharma Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hainan Poly Pharm Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Yangzijiang Pharmaceutical Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Shionogi Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Dawnrays Pharma Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Zhejiang Wolwo Bio-Pharma Anti-allergic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
